The group’s principle activities include developing, marketing and distributing injectable pharmaceuticals. The group’s products include ephedrine sulfate injection, USP, fludarabine phosphate injection, L-Cysteine hydrochloride injection, USP, and paclitaxel injection, USP. The group operates from United States.
